Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_assertion type Assertion NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_head.
- NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_assertion description "[The efficacy of the ACE (angiotensin-converting enzyme) inhibitor perindopril in coronary artery disease [EUROPA (European trial on reduction of cardiac events with perindopril in stable coronary artery disease) study] is associated with the rs12050217 A/G single nucleotide polymorphism in the B1 receptor (bradykinin type 1 receptor) gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_provenance.
- NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_assertion evidence source_evidence_literature NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_provenance.
- NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_assertion SIO_000772 24117346 NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_provenance.
- NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_assertion wasDerivedFrom befree-20140225 NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_provenance.
- NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_assertion wasGeneratedBy ECO_0000203 NP156624.RA1V-eQmPmU16YyRqupHkehubwpYNUVKPXRRqpetLgNic130_provenance.